A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health data.
Microneedle vaccine patch company raises $50M for pivot to GLP-1 delivery
Fourteen years ago, a group of Harvard Business School students launched a startup called Vaxess Technologies with a goal to disrupt the vaccine industry by replacing needles with a simple skin patch. Getting the technology …
AI-Native Security Is a Must to Counter AI-Based Attacks
Attacks by artificial intelligence agents are a reality. Experts at Nvidia’s GTC conference say defenders need to use the same tools to fight them off.
Can ChatGPT-5 educate the public about vasectomy?: a Google Trends–based expert panel assessment
BackgroundChatGPT-5, the latest multimodal large language model (LLM), has gained remarkable public attention for its ability to provide real-time and context-aware health information. However, its effectiveness in addressing sensitive urological topics such as vasectomy has not been systematically evaluated.ObjectiveThis study aimed to evaluate the accuracy, completeness and public suitability of ChatGPT-5’s responses to frequently asked […]
Intelligence without intuition: a mixed-methods pilot study on reasoning models in musculoskeletal physiotherapy for low-back pain
Musculoskeletal pain, especially low-back pain, is highly prevalent and often challenging to manage due to its multifactorial nature. Effective diagnosis and therapy require clinicians to integrate biopsychosocial information within an evidence-based clinical reasoning framework. Large language models that “think” before responding, so-called reasoning models, show promise to support such complex decision-making, yet their validity and […]
Novo unveils first data for ‘triple G’ agonist in diabetes
Novo Nordisk has reported the first clinical data with its triple G agonist for diabetes, in China, as it starts an international trials programme.
Ex-NSA Directors Discuss ‘Red Line’ for Offensive Cyberattacks
Four former NSA chiefs representing a near-complete history of US Cyber Command debated and discussed the role of offensive cyber in the government.
Agentic commerce runs on truth and context
Imagine telling a digital agent, “Use my points and book a family trip to Italy. Keep it within budget, pick hotels we’ve liked before, and handle the details.” Instead of returning a list of links, the agent assembles an itinerary and executes the purchase. That shift, from assistance to execution, is what makes agentic AI […]
Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
Novartis is facing a class-action lawsuit alleging it shared, without patients’ consent, sensitive health information it collected from visitors to its consumer-facing branded drug websites.
Maze meets own expectations in Phase 2 kidney disease trial in the same arena as Vertex
Maze Therapeutics unveiled positive mid-stage data for its genetic kidney disease drug that could spell major competition for Vertex Pharmaceuticals’ program that has the same target. Maze’s candidate, codenamed MZE829, produced an average 35.6% reduction …
Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis’ Scemblix
Merck is looking to further solidify its oncology pipeline via a $6.7 billion cash acquisition of Terns Pharmaceuticals and its investigational treatment for chronic myeloid leukemia. The Wednesday morning M&A move gives the New Jersey …
AI in drug discovery and development: news watch
Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.